Pfizer, Valneva announce 'positive' results for Lyme disease vaccine candidate booster shotReuters • 09/07/23
Valneva and Pfizer Report Positive Pediatric and Adolescent Phase 2 Booster Results for Lyme Disease Vaccine CandidateGlobeNewsWire • 09/07/23
Is Pfizer Stock A Buy Or A Sell With Covid-Era Growth In The Rearview?Investors Business Daily • 09/06/23
UK joins EU in approving XBB.1.5 jab from Pfizer-BioNTech, but others subvariants are emergingProactive Investors • 09/06/23